Brief: Servier And Day One Biopharmaceuticals Announce Acquisition To Expand Servier’S Rare Oncology Portfolio
06/03/2026 13:31
March 6 (Reuters) - Day One Biopharmaceuticals Inc DAWN.O: SERVIER AND DAY ONE BIOPHARMACEUTICALS ANNOUNCE ACQUISITION TO EXPAND SERVIER’S RARE ONCOLOGY PORTFOLIO DAY ONE BIOPHARMACEUTICALS INC - SERVIER TO BUY DAY ONE FOR $21.50 PER SHARE, TOTAL EQUITY VALUE $2.5 BILLION DAY ONE BIOPHARMACEUTICALS INC - SERVIER EXPECTS TO FUND DEAL THROUGH EXISTING CASH AND INVESTMENTS Source text: ID:nGNX1QNHQg Further company coverage: DAWN.O ((Reuters.Briefs@thomsonreuters.com;))